As we look ahead to 2025, a number of factors poise the clinical laboratory market for continued transformation. The post-COVID-19 landscape is reshaping the industry, presenting both challenges and ...
Wall Street loves a good David versus Goliath story. But what happens when two Davids are battling entirely different giants? Rocket Lab reported $123 million in first-quarter 2025 revenue, reflecting ...
Investors in the commercial space industry are showing increased interest in Rocket Lab USA, Inc. (NASDAQ: RKLB). Due to its focus on innovation and market demands, the company has grown from a small ...
Rocket Lab is on track for 'a similarly aggressive growth trajectory as SpaceX,' writes KeyBanc Capital Markets analyst Michael Leshock Rocket Lab USA Inc.'s stock initially tumbled in the wake of the ...
Rocket Lab reported 69% sales growth in its Q1 earnings report, but still missed analyst targets. Rocket Lab is growing sales nicely, but still isn't profitable. A big defense contract won in late ...
CEO Patrick Kaltenbach highlighted a strong finish to 2024 with excellent performance in laboratory products, particularly in Europe. He emphasized the company’s focus on long-term strategies, ...
Investors in the commercial space industry are showing increased interest in Rocket Lab USA, Inc. (NASDAQ: RKLB). Due to its focus on innovation and market demands, the company has grown from a small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results